These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Botulin toxin injections in cosmetic treatment of men]. Gassia V Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S119-24. PubMed ID: 19576477 [TBL] [Abstract][Full Text] [Related]
44. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications. de Almeida AT; De Boulle K J Cosmet Laser Ther; 2007; 9 Suppl 1():17-22. PubMed ID: 17885882 [TBL] [Abstract][Full Text] [Related]
45. [Can the botulinum toxin prevent aging?]. Le Louarn C Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S92-103. PubMed ID: 19576493 [TBL] [Abstract][Full Text] [Related]
46. Handling botulinum toxins: an updated literature review. Trindade De Almeida AR; Secco LC; Carruthers A Dermatol Surg; 2011 Nov; 37(11):1553-65. PubMed ID: 21777338 [TBL] [Abstract][Full Text] [Related]
47. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410 [TBL] [Abstract][Full Text] [Related]
48. Complications of botulinum toxin A use in facial rejuvenation. Vartanian AJ; Dayan SH Facial Plast Surg Clin North Am; 2003 Nov; 11(4):483-92. PubMed ID: 15062253 [TBL] [Abstract][Full Text] [Related]
49. Clinical comparisons of botulinum neurotoxin formulations. Brashear A Neurologist; 2008 Sep; 14(5):289-98. PubMed ID: 18784598 [TBL] [Abstract][Full Text] [Related]
50. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. de Boulle K J Cosmet Laser Ther; 2008 Jun; 10(2):87-92. PubMed ID: 18569261 [TBL] [Abstract][Full Text] [Related]
51. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. Farahvash MR; Arad S J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691 [TBL] [Abstract][Full Text] [Related]
52. Update on botulinum neurotoxin use in aesthetic dermatology. Ibrahim O; Keller EC; Arndt KA Semin Cutan Med Surg; 2014 Dec; 33(4):152-6. PubMed ID: 25830246 [TBL] [Abstract][Full Text] [Related]
53. Botulinum toxins for facial wrinkles: beyond glabellar lines. Dayan SH; Maas CS Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554 [TBL] [Abstract][Full Text] [Related]
54. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction. Rajkumar GN; Conn IG Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922 [No Abstract] [Full Text] [Related]
55. [Botulinum toxin--phenomenon of poison]. Berny-Moreno J; Barancewicz-Losek M Pol Merkur Lekarski; 2006 Apr; 20(118):482-5. PubMed ID: 16886581 [TBL] [Abstract][Full Text] [Related]
56. Botulinum toxins: pharmacology and its current therapeutic evidence for use. Panicker JN; Muthane UB Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921 [TBL] [Abstract][Full Text] [Related]